S 2374 New Jersey Senate · 2026-2027 Regular Session

Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.

This bill prohibits health insurers, pharmacy benefits managers, and state health programs from requiring pre-approval or precertification for cancer-related treatments, tests, procedures, or prescription drugs covered under health or prescription drug plans. It directly affects cancer patients and their licensed healthcare providers by ensuring these covered services are paid for without insurance company delays when prescribed for a diagnosed cancer patient. Key provisions ban pre-approval requirements for any covered cancer treatment, test, procedure, or drug under state health plans, state employee health programs, and private insurance. The law applies immediately to all health plans issued or purchased after enactment.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
2 primary · 0 co-sponsors

Sponsors